Company Directory / research
PrivateFor profitresearchBoston, United States
Nimbus Therapeutics
Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.
- Founded
- 2009 17 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $637M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
17 years old.
Reach
Website ranked #2,999,917 in the world for traffic, about 5k visits a month.
What it does
BiotechnologyHealth CareTherapeutics
Funding, as listed
$637M currency not stated
- Rounds9
- LatestPrivate equity, Sept 2023
- Investors19, 9 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Nimbus Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Nimbus Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2009
- Founders
- Bruce Booth
- Industry
- research
- Categories
- Biotechnology, Health Care, Therapeutics
Where
- City
- Boston
- Country
- United States
- Markets
- Greater Boston Area, East Coast, New England, Northeastern US
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #2,999,917
- Monthly web visits
- 5,206
Funding, as listed
- Total
- 637,000,000 (currency not stated)
- Rounds
- 9
- Latest round
- Private equity
- Latest round date
- Sept 2023
- Investors
- 19
- Lead investors
- 9
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Nimbus Therapeutics may be growing as evidenced by the expansion of its immunology drug discovery pipeline, which indicates an increase in its research and development activities. Furthermore, the company has presented new positive clinical data for its HPK1 inhibitor, suggesting progress in its clinical trials and potential for future revenue streams. Additionally, Nimbus Therapeutics is listed among key companies in the psoriasis market, which is projected to experience incremental growth, implying that the company is well-positioned in a growing market segment.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.